Skip to search formSkip to main contentSkip to account menu

Reteplase

Known as: t-plasminogen activator, reteplase [Chemical/Ingredient], tPA 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
The preservation of privacy of published microdata is essential to prevent the sensitive information of individuals from being… 
2015
2015
Cardiovascular and cerebrovascular diseases are leading causes of morbidity and mortality for human beings, and thrombosis is the… 
2014
2014
Although streptokinase and tissue plasminogen activators tenecteplase, reteplase and alteplase are in clinical use for Acute ST… 
2012
2012
Objectives To explore the clinical effect of reteplase in the emergency use of thrombolytic therapy in patients with pulmonary… 
2004
2004
SummaryThe case report describes the successful thrombolysis with reteplase (Rapilysin®) of a 66-year-old woman with massive… 
2004
2004
OBJECTIVE To obtain the recombinant human tissue-type plasminogen activator mutant(reteplase,r-PA) with high purity and high… 
1999
1999
#### Glossary COMPASS, : Comparison trial of saruplase and streptokinase GISSI, : Gruppo Italiano per lo studio della… 
1998
1998
Reteplase but not Alteplase Affects Early Soluble PECAM-1 and P-selectin Release in Patients with Acute Myocardial Infarction - 
1975
1975
A sequence IA_ I00 is said to be an interpolating sequence for L2(7T, 7z) if the system of equations iriA t cn =f f(t)e in dt…